PlainRecalls
FDA Drug Moderate Class II Terminated

HPC Tablet (Acetaminophen 110 mg, Aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62969-242-00

Reported: February 16, 2022 Initiated: January 26, 2022 #D-0538-2022

Product Description

HPC Tablet (Acetaminophen 110 mg, Aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62969-242-00

Reason for Recall

CGMP Deviations

Details

Units Affected
50,585,623 tablets
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.
Location
Highland, NY

Frequently Asked Questions

What product was recalled?
HPC Tablet (Acetaminophen 110 mg, Aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62969-242-00. Recalled by ULTRAtab Laboratories, Inc.. Units affected: 50,585,623 tablets.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on February 16, 2022. Severity: Moderate. Recall number: D-0538-2022.